Minimize Uncertainty – Make Informed Decisions – Succeed

Public_Health

Latest Public Health News - Sept 11th to Sept 25

September 26, 2025telomeres,Childhood myopia,AI in healthcare,Public Health News,PDAC,Longevity,BioPharma and Tech News,Pancreatic cancer,air pollution,UK Biobank,CRISPRa,Delphi-2M,Skin cancer,nicotinamide,squamous cell carcinomaNeurodevelopmental disorders,SCN2A

Watch Our Video Summary Capturing Top Public Health News from the Last Two…

by LucidQuest

Respiratory

Respiratory Today—September 26, 2025

September 26, 2025BATURA,smoking cessation,MANDALA,ENFLONSIA,IPF,DENALI,clesrovimab,Amgen,mild asthma,CLEVER,astrazeneca,severe exacerbation,SMART,merck,United Therapeutics,Respiratory News,msd,Tyvaso,COPD,treprostinil,BioPharma and Tech News,inhalation solution,RSV Prevention,TETON-2,Tezepelumab,Tezspire,Idiopathic Pulmonary Fibrosis,WAYPOINT,CRSwNP,Achieve Life Sciences,AIRSUPRA,Cytisinicline,albuterol,ORCA-2budesonide,ORCA-3

Respiratory Health Update: AIRSUPRA Label Expansion, TETON-2 IPF Win, Tezspire…

by LucidQuest

Cardiovascular

Latest Cardiovascular News - Sept 10th to Sept 24th 2025

September 25, 2025Cardiovascular News,BioPharma and Tech NewsTAVI,Medtronic,ELEVATE-HFpEF,conduction-system pacing,Cedars-Sinai,SAVR,Sutra Medical,Neurescue,MR repair,TEER-ineligible,Imperative Care,SYMP,hearth health

Watch Our Video Summary Capturing Cardiovascular News from the Last Two Weeks…

by LucidQuest

Rare Disease news

Latest Rare Diseases News - Sept 10th to Sept 24th 2025

September 25, 2025Thyroid Eye Disease,Fibrodysplasia Ossificans Progressiva,astrazeneca,Rare Disease News,Duchenne Muscular Dystrophy,Huntington's disease,BioPharma and Tech News,Regeneron,Avidity Biosciences,Selumetinib,Maze Therapeutics,Viridian Therapeutics,KOSELUGO,Stealth BioTherapeutics,IonisSkyhawk Therapeutics,Neurofibromatosis Type 1

Watch Our Video Summary Capturing Top Rare Disease News from the Last Two……

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - September 25th 2025

September 25, 2025deramiocel,hematopoietic stem cell gene therapy,eXmoor Pharma,CAP-1002,BlueRock,Siam Bioscience,Amgen,HOPE-3,bemdaneprocel,CGT manufacturing,bayer,PUL 2.0,BRT-DA01,Cell and Gene Therapy News,janssen,Kinea Bio,AskBio,Spinraza,KNA-155,AB-1005,Multiple Myeloma,dysferlinopathy,GDNF,BioPharma and Tech News,DYSF,Uplizna,CHMP,AAV-SLB101,inebilizumab,Parkinson's,Solid Biosciences,IgG4-RD,SMA,MavriX Bio,MITIGATE,Angelman Syndrome,MVX-220,OCLI Vision,Biogen,GEMMABio,ENCELTO,Legend,UC Davis,inherited retinal disease,Cilta-cel,CIRM,CARTITUDE-4,Capricor TherapeuticsUBE3A,REMS

Gene & Cell Therapy Update: Remedium–Lilly Obesity Pact, RMAT for…

by LucidQuest

Rare Disease news

Rare Diseases Weekly News - September 30th 2025

September 25, 2025ublituximab-xiiy,UnitedHealthcare,Kisunla,BRAF paradox breaker,abbvie,donanemab,Eisai,novartis,Tavapadon,lecanemab,Huntington's disease,Lundbeck,LEQEMBI,BioPharma and Tech News,American Migraine Foundation,D1/D5 agonist,Eli Lilly,Association of Migraine Disorders,Theranica,Biogen,Nira Medical,Pier 88 Health,TG Therapeutics,Century Health,Nerivio,BRIUMVI,CHARM study,Remote Electrical Neuromodulation,AMT-130,Rocky Mountain MS Clinic,Rare Disease News,uniQure,Kyverna Therapeutics,Fore Biotherapeutics,KYV-101,plixorafenib,CD19 CAR-T,Kesimpta,Plus Therapeuticsofatumumab,CNSide CSF assay

🧬 This Week in Rare Diseases: FDA Label Expansion, Accelerated Approvals, RNA…

by LucidQuest

Cardiovascular

Cardiovascular Weekly News - September 25th 2025

September 25, 2025Imperative Care SYMPHONY-PE,pulmonary embolism,health disparities,Heart Valve Voice UK,semaglutide,SCAI Door to Lactate Clearance,BioPharma and Tech News,cardiogenic shock,HEART FAILURE,Humacyte CTEV,Tirzepatide,ATEV,rheumatoid arthritis,CABG,Cardiovascular Risk,CeleCor zalunfiban,GLP-1 RA,DisaggproT,Pregabalin,STEMI,Gabapentin,Ultromics EchoGo,pediatric cardiology,amyloidosis,cardiac rehabilitation,cardiac amyloidosis,CHDCardiovascular News,mammography AI

Cardiovascular Update: NEURESCUE CE Mark, HFpEF Pacing Trial, Bicuspid Valve…

by LucidQuest

Neuroscience

Neuroscience Weekly News - September 24th 2025

September 24, 2025B-cell therapy,National MS Society,Hospitalization,McDonald criteria 2024,FDA,Hypogammaglobulinemia,Neuroscience News,roche,MAVENCLAD,sanofi,cladribine tablets,Genentech,Merck KGaA,BioPharma and Tech News,EMD Serono,Gemini,PIRA,BTK Inhibitor,Brain volume,RRMS,Neuraxpharm,tolebrutinib,nrSPMS,HERCULES,JCR Pharmaceuticals,TG Therapeutics,Alexion,ECTRIMS,AstraZeneca Rare Disease,Ocrelizumab,J-Brain CargoRituximab,JUST-AAV

🧠 This Week in Neuroscience: Ocrelizumab Safety, MAVENCLAD Durability, ECTRIMS…

by LucidQuest

ECTRIMS 2025 Preview: Key Multiple Sclerosis Highlights to Watch

September 24, 2025Our Insights,multiple sclerosisLucidQuest,BTK Inhibitors,tolebrutinib,Biomarkers,Conference Previews,AI in neurology,ECTRIMS 2025,RIS,pregnancy,RAM endpoints

ECTRIMS 2025 at a glance Ahead of ECTRIMS 2025 in Barcelona, see what to…

by LucidQuest

Obesity Weekly News

Obesity Weekly News - September 23rd 2025

September 24, 2025lanifibranor,Reuters,PPAR-α/δ/γ,GlobalData,semaglutide,Resalis,NRDD,pfizer,RES-010,DealForma,roche,miR-22,Obesity News,BioPharma and Tech News,ASO,mazdutide,Innovent,Ascletis,NMPA,dual GCG/GLP-1,Metsera,ASC47,MET-097i,THRβ,MET-233i,Helmholtz,monthly GLP-1,DZD,amylin,quintuple agonist,CT-388,GLP-1R,CarmotGIPR,China in-licensing

Obesity Update: ASC47 Combo Gains, Quintuple Agonist, Mazdutide Launch,…

by LucidQuest

Immunology

Immunology Weekly News - September 24th 2025

September 24, 2025Camoteskimab,Anti-IL-18,BioPharma and Tech News,Immunology News,TREMFYA,Bimekizumab,Icotrokinra,Sotyktu,BIMZELX,Ritlecitinib,Litfulo,Cetaphil Skin Activator,Ruxolitinib Cream,Opzelura,TildrakizumabIL-23 Inhibitor,Sensitive Skin Research

Immunology Update: Bimekizumab Durability, Icotrokinra Win, Ritlecitinib AA…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Salt AI $10M raise

September 24, 2025digital health,AI in healthcare,clinical development,biopharma,Lucid Diligence Brief,payer access,life sciences software,discovery platforms,compliance,model ops,venture fundingworkflow orchestration

Lucid Diligence Brief: Salt AI $10M raise Professional audiences only. Not…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.